Literature DB >> 24246474

Dendritic cells in progression and pathology of HIV infection.

Olivier Manches1, Davor Frleta1, Nina Bhardwaj2.   

Abstract

Although the major targets of HIV infection are CD4⁺ T cells, dendritic cells (DCs) represent a crucial subset in HIV infection because they influence viral transmission and target cell infection and presentation of HIV antigens. DCs are potent antigen-presenting cells that can modulate antiviral immune responses. Through secretion of inflammatory cytokines and interferons (IFNs), DCs also alter T cell proliferation and differentiation, participating in the immune dysregulation characteristic of chronic HIV infection. Their wide distribution in close proximity with the mucosal epithelia makes them one of the first cell types to encounter HIV during sexual transmission. We discuss here the multiple roles that DCs play at different stages of HIV infection, emphasizing their relevance to HIV pathology and progression.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dendritic; HIV; Immune activation; Infection; Pathogenesis

Mesh:

Year:  2013        PMID: 24246474      PMCID: PMC3943663          DOI: 10.1016/j.it.2013.10.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  125 in total

1.  Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome.

Authors:  Scott A Handley; Larissa B Thackray; Guoyan Zhao; Rachel Presti; Andrew D Miller; Lindsay Droit; Peter Abbink; Lori F Maxfield; Amal Kambal; Erning Duan; Kelly Stanley; Joshua Kramer; Sheila C Macri; Sallie R Permar; Joern E Schmitz; Keith Mansfield; Jason M Brenchley; Ronald S Veazey; Thaddeus S Stappenbeck; David Wang; Dan H Barouch; Herbert W Virgin
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

2.  HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.

Authors:  Davor Frleta; Carolyn E Ochoa; Holger B Kramer; Shaukat Ali Khan; Andrea R Stacey; Persephone Borrow; Benedikt M Kessler; Barton F Haynes; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

3.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

4.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

5.  Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.

Authors:  Elizabeth A Miller; Meredith R Spadaccia; Meagan P OʼBrien; Linda Rolnitzky; Rachel Sabado; Olivier Manches; Davor Frleta; Nina Bhardwaj
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

Review 6.  Microbial translocation, immune activation, and HIV disease.

Authors:  Nichole R Klatt; Nicholas T Funderburg; Jason M Brenchley
Journal:  Trends Microbiol       Date:  2012-10-11       Impact factor: 17.079

7.  A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.

Authors:  Felipe García; Nuria Climent; Alberto C Guardo; Cristina Gil; Agathe León; Brigitte Autran; Jeffrey D Lifson; Javier Martínez-Picado; Judit Dalmau; Bonaventura Clotet; Josep M Gatell; Montserrat Plana; Teresa Gallart
Journal:  Sci Transl Med       Date:  2013-01-02       Impact factor: 17.956

8.  Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes.

Authors:  Jill Henault; Jennifer Martinez; Douglas R Green; Miguel A Sanjuan; Jeffrey M Riggs; Jane Tian; Payal Mehta; Lorraine Clarke; Miwa Sasai; Eicke Latz; Melanie M Brinkmann; Akiko Iwasaki; Anthony J Coyle; Roland Kolbeck
Journal:  Immunity       Date:  2012-12-06       Impact factor: 31.745

9.  Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection.

Authors:  N R Klatt; J D Estes; X Sun; A M Ortiz; J S Barber; L D Harris; B Cervasi; L K Yokomizo; L Pan; C L Vinton; B Tabb; L A Canary; Q Dang; V M Hirsch; G Alter; Y Belkaid; J D Lifson; G Silvestri; J D Milner; M Paiardini; E K Haddad; J M Brenchley
Journal:  Mucosal Immunol       Date:  2012-05-30       Impact factor: 7.313

10.  Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection.

Authors:  Caroline Goujon; Torsten Schaller; Rui Pedro Galão; Sarah M Amie; Baek Kim; Kevin Olivieri; Stuart J D Neil; Michael H Malim
Journal:  Retrovirology       Date:  2013-02-25       Impact factor: 4.602

View more
  35 in total

Review 1.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

Review 2.  The role of human dendritic cells in HIV-1 infection.

Authors:  Zahra Ahmed; Tatsuyoshi Kawamura; Shinji Shimada; Vincent Piguet
Journal:  J Invest Dermatol       Date:  2014-11-19       Impact factor: 8.551

Review 3.  HIV infection: focus on the innate immune cells.

Authors:  Milena S Espíndola; Luana S Soares; Leonardo J Galvão-Lima; Fabiana A Zambuzi; Maira C Cacemiro; Verônica S Brauer; Fabiani G Frantz
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

Review 4.  Roles of autophagy in HIV infection.

Authors:  Christina Dinkins; Manohar Pilli; John H Kehrl
Journal:  Immunol Cell Biol       Date:  2014-11-11       Impact factor: 5.126

5.  p21 Restricts HIV-1 in Monocyte-Derived Dendritic Cells through the Reduction of Deoxynucleoside Triphosphate Biosynthesis and Regulation of SAMHD1 Antiviral Activity.

Authors:  Jose Carlos Valle-Casuso; Awatef Allouch; Annie David; Gina M Lenzi; Lydia Studdard; Françoise Barré-Sinoussi; Michaela Müller-Trutwin; Baek Kim; Gianfranco Pancino; Asier Sáez-Cirión
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 6.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

Review 7.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

8.  MALDI Mass Spectrometry Imaging Reveals Heterogeneous Distribution of Tenofovir and Tenofovir Diphosphate in Colorectal Tissue of Subjects Receiving a Tenofovir-Containing Enema.

Authors:  Herana Kamal Seneviratne; Craig W Hendrix; Edward J Fuchs; Namandjé N Bumpus
Journal:  J Pharmacol Exp Ther       Date:  2018-07-23       Impact factor: 4.030

Review 9.  Human Immunodeficiency Virus Infection and Host Defense in the Lungs.

Authors:  Tysheena P Charles; Judd E Shellito
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

10.  HIV-1 gp120 activates the STAT3/interleukin-6 axis in primary human monocyte-derived dendritic cells.

Authors:  Manuela Del Cornò; Gloria Donninelli; Barbara Varano; Letizia Da Sacco; Andrea Masotti; Sandra Gessani
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.